Grants for State governments - Science and Technology

The United States Agency for International Development (USAID) is issuing this Broad Agency Announcement (BAA) to seek participants to co-create, co-design, co-invest, and collaborate on creating, piloting, and scaling innovative research and development interventions utilizing innovative health practices to help reduce disease and mortality rates worldwide. USAID invites organizations and companies to submit an Expression of Interest (EOI) and participate in generating novel tools and approaches that accelerate and sustain improved health outcomes in low-and-middle-income countries (LMICs). The intent of the BAA is to allow co-creation and co-design to the maximum extent to create high quality, effective partnerships with great efficiency in time and resources. USAID is seeking new applications of research development, science, partnerships, and innovative practices in global health that provide the best value to the Government. USAID will invite selected for-profit and non-profit, public and private organizations, as detailed below, to co-create innovative research and development (R) solutions to the Problem and Challenge Statements stated in this BAA, including those organizations that have ideas, expertise, resources, and/or funding to add to potential solutions. In particular, this BAA welcomes co-creation from local partners based in LMICs, including the private sector, faith-based organizations, and other non-traditional USAID partners, to increase the presence and voices of local populations in solving their own health challenges.The intent of the BAA is to enable and encourage co-creation and co-design in order to generate high quality ideas and effective partnerships with improved efficiency in time and resources. Other types of collaboration can also include co-investing:Co-Investing: USAID wants to align goals with the partners under this BAA, to facilitate shared responsibility, shared risk, and shared resourcing. Shared resourcing requires that cash and other resources, both tangible and intangible, such as in-kind contributions, expertise, intellectual property, brand value, high-value coordination, and access to key people, places, and information, are directed towards reaching the solution to the Problem/Challenge. Co-investing does not require equal shared resources (such as 1:1 leverage), but rather resource contributions that are appropriate to the specific projects objectives, considering the comparative advantages brought by the participation of each party.

This funding opportunity provides financial support for innovative research in advanced scientific computing and extreme-scale science, targeting a wide range of applicants including universities, for-profit companies, and federal laboratories, to tackle challenges in high-performance computing, quantum technologies, and artificial intelligence.

This funding opportunity supports Anne Arundel County Public School clubs and youth organizations in implementing peer-led education programs focused on preventing substance misuse among youth.

This funding opportunity supports research projects that use genome editing techniques to explore the genetic factors contributing to substance use disorders, encouraging diverse organizations to participate in advancing addiction science.

This grant provides funding for researchers and organizations to develop innovative technologies and processes that improve water treatment methods, reduce costs and environmental impacts, and enhance the efficiency of desalination and water purification systems.

This funding opportunity is designed for research institutions affiliated with the Desert Southwest Cooperative Ecosystem Studies Unit to study vegetation health and water use in the Lower Colorado River's riparian areas using remote sensing technologies.

This funding opportunity provides financial support to medical examiner and coroner offices for accreditation and to develop forensic pathology fellowships, addressing workforce shortages and improving death investigation standards nationwide.

This funding opportunity provides financial support for research and development projects that improve forensic science practices and technologies, targeting a wide range of eligible entities including government agencies, educational institutions, and nonprofit organizations.

This funding opportunity supports a variety of organizations in California to develop and implement safer, sustainable pest management practices that protect public health and the environment while promoting economic vitality.

The anticipated funding opportunity announcement (FOA) aims to support research and development projects under the Vehicle Technologies Office (VTO). The goals include the demonstration of smart charge management for electric vehicles, improvement of 12-volt lead-acid batteries for safety-critical electric vehicle applications, development of strategies to reduce the likelihood of cascading effects of electric vehicle fires, reduction in battery electrode, cell, and pack manufacturing costs, advancement of silicon-based anodes for lithium-ion batteries, and development of high-energy density conversion cathodes. The FOA emphasizes advancing equity, addressing the climate crisis, and achieving net-zero emissions by 2050. Eligible applicants are encouraged to include underrepresented groups and underserved communities in their project teams. The FOA will fund activities related to electric vehicle (EV) technologies, focusing on areas such as smart charge management, safety improvements in EV batteries, cost reduction in battery manufacturing, and the development of advanced battery materials. The Department of Energy aims to drive innovation in clean energy technologies, ensuring environmental justice and inclusion. Specific areas of interest include wide-scale demonstrations of smart charge management, enhancement of safety-critical 12-volt lead-acid batteries, reduction of cascading effects of battery fires, cost reduction in battery manufacturing, and the development of high-energy-density battery components.

This program provides financial assistance to small business and commercial property owners in Jackson, Mississippi, to improve the appearance of their buildings and attract more customers and investors.

The Arts & Cultural Organizations General Operating Support grant program, offered by the California Arts Council, provides direct funding to arts and cultural organizations for their ongoing operations. This grant is designed to support the overall well-being of California's cultural vitality by sustaining a robust and diverse arts workforce and infrastructure. The funding is intended to support the applicant organization in carrying out its mission, rather than a specific project, aligning with a strategic priority to foster a stable and thriving arts ecosystem across the state. The target beneficiaries are arts and cultural organizations within California, specifically those with total revenue between $250,000 and $1.5 million. This focus aims to support a crucial segment of the cultural sector, enabling them to continue their work. The impact goals include enhancing the sustainability and resilience of these organizations, ensuring they can contribute to California's cultural landscape. The program prioritizes eligible expenses associated with general operations, such as rent, utilities, and staff salaries. This focus on operational support allows organizations to maintain their core functions, which is critical for long-term stability. The expected outcomes include the sustained operation of arts and cultural organizations, the retention of a diverse arts workforce, and the continued delivery of cultural services to communities throughout California. Measurable results for this one-year funding cycle could include the number of organizations sustained, the range of eligible expenses covered, and the continued employment of arts professionals. The grant activity period is from October 1, 2024, to September 30, 2025. This grant indirectly supports the California Arts Council's broader theory of change, which posits that investing in the operational capacity of arts organizations leads to a more vibrant, accessible, and equitable cultural environment for all Californians.

This funding opportunity supports early-stage research aimed at improving understanding and treatment of rare autoimmune neuropathies affecting the peripheral nervous system, specifically targeting innovative approaches to disease mechanisms, biomarkers, and therapies.

This grant provides funding to state and local governments to conduct DNA testing and improve evidence preservation in violent felony cases, helping to address wrongful convictions and support justice.

This funding opportunity provides financial support to state and local governments in Maryland for outdoor recreation projects, including land acquisition and the development or renovation of recreational facilities.

The FY24 PCRP Exploration Hypothesis Development Award supports the exploration of highly innovative, untested, potentially high-gain concepts, theories, paradigms, and/or methods that address an important problem relevant to one or more of the FY24 PCRP Overarching Challenges. This award is designed to provide investigators the opportunity to pursue serendipitous observations that may reveal entirely new avenues for investigation. Results of studies conducted through this award may provide the scientific premise upon which a new hypothesis can be based or initial proof of principle of an innovative hypothesis, laying the groundwork for future avenues of scientific investigation. Presentation of preliminary data is inconsistent with the intent of this award mechanism and is therefore strongly discouraged. However, logical reasoning and a sound scientific rationale for the proposed work must be described. Reviewers will be blinded to the identity of the Principal Investigator (PI), collaborator(s), and their organization(s). Refer to Section II.D.2.b.i, Full Application Submission Type, for more information. New for FY24: Clinical research is allowed. For the purposes of this funding opportunity, research that meets the definition of a clinical trial is distinct from clinical research. Clinical research encompasses research with human data, human specimens, and/or interaction with human subjects. Clinical research is observational in nature and includes: (1) Research conducted with human subjects and/or material of human origin such as data, specimens, and cognitive phenomena for which an investigator (or co-investigator) does not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention. Research meeting this definition may include but is not limited to: (a) mechanisms of human disease, (b) diagnostic or detection studies (e.g., biomarker or imaging), (c) health disparity studies, and (d) development of new technologies. (2) Epidemiologic and behavioral studies that do not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention. (3) Outcomes research and health services research that do not fit under the definition of clinical trial. Excluded from the definition of clinical research are in vitro studies that utilize human data or specimens that cannot be linked to a living individual and meet the requirements for exemption under 46.104(d)(4) of the Common Rule. Clinical trials are not allowed. A clinical trial is defined in the Code of Federal Regulations, Title 45, Part 46.102 (45 CFR 46.102) as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include a placebo or another control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes. Studies that do not seek to measure safety, effectiveness, and/or efficacy outcome(s) of an intervention are not considered clinical trials. A congressionally mandated Metastatic Cancer Task Force was formed with the purpose of identifying ways to help accelerate clinical and translational research aimed at extending the lives of advanced state and recurrent patients. As a member of the Metastatic Cancer Task Force, the CDMRP encourages applicants to review the recommendations (https://health.mil/Reference-Center/Congressional-Testimonies/2018/05/03/Metastatic-Cancer Research) and submit research ideas to address these recommendations provided they are within the limitations of this funding opportunity and fit within the FY24 PCRP priorities. Innovative research involving nuclear medicine and related techniques to support early diagnosis, more-effective treatment, and improved health outcomes of active-duty Service Members and their Families is encouraged. Such research could improve diagnostic and targeted treatment capabilities through noninvasive techniques and may drive the development of precision imaging and advanced targeted therapies. Applications from investigators within the military services and applications involving multidisciplinary collaborations among academia, industry, the military services, the U.S. Department of Veterans Affairs (VA), and other federal government agencies are highly encouraged. These relationships can leverage knowledge, infrastructure, and access to unique clinical populations that the collaborators bring to the research effort, ultimately advancing research that is of significance to Service Members, Veterans, and/or their Families. If the proposed research relies on access to unique resources or databases, the application must describe the access at the time of submission and include a plan for maintaining access as needed throughout the proposed research. All projects should adhere to a core set of standards for rigorous study design and reporting to maximize the reproducibility and translational potential of clinical and preclinical research. The standards are described in SC Landis et al., 2012, A call for transparent reporting to optimize the predictive value of preclinical research, Nature 490:187-191 (https://www.nature.com/nature/ journal/v490/n7419/full/nature11556.html). While these standards are written for preclinical studies, the basic principles of randomization, blinding, sample-size estimation, and data handling derive from well-established best practices in clinical studies. The funding instrument for awards made under the program announcement will be grants (31 USC 6304). The anticipated direct costs budgeted for the entire period of performance for an FY24 Exploration Hypothesis Development Award should not exceed $150,000. Refer to Section II.D.5, Funding Restrictions, for detailed funding information. Awards supported with FY24 funds will be made no later than September 30, 2025. The CDMRP expects to allot approximately $3.60M to fund approximately 15 Exploration Hypothesis Development Award applications. Funding of applications received is contingent upon the availability of federal funds for this program, the number of applications received, the quality and merit of the applications as evaluated by peer and programmatic review, and the requirements of the government. Funds to be obligated on any award resulting from this funding opportunity will be available for use for a limited time period based on the fiscal year of the funds. It is anticipated that awards made from this FY24 funding opportunity will be funded with FY24 funds, which will expire for use on September 30, 2030. Research Involving Animals: All research funded by the FY24 PCRP Exploration-Hypothesis Development Award involving new and ongoing research with animals must be reviewed and approved by the USAMRDC Office of Human and Animal Research Oversight (OHARO; previously the Human Research Protection Office), Animal Care and Use Review Office (ACURO), in addition to the local Institutional Animal Care and Use Committee (IACUC) of record. IACUC approval at the time of submission is not required. Allow at least 3 to 4 months for ACURO regulatory review and approval processes for animal studies. Refer to the General Application Instructions for additional information.

To obtain a copy of the Funding Opportunity Announcement (FOA) please go to the ARPA-E website at https://arpa-e-foa.energy.gov. To apply to this FOA, Applicants must register with and submit application materials through ARPA-E eXCHANGE (https://arpa-e-foa.energy.gov/Registration.aspx). For detailed guidance on using ARPA-E eXCHANGE, please refer to the ARPA-E eXCHANGE User Guide (https://arpa-e-foa.energy.gov/Manuals.aspx). ARPA-E will not review or consider concept papers submitted through other means. For problems with ARPA-E eXCHANGE, email [email protected] (with FOA name and number in the subject line). Questions about this FOA? Check the Frequently Asked Questions available at http://arpa-e.energy.gov/faq. For questions that have not already been answered, email [email protected]. The purpose of this modification is to incorporate changes to Funding Opportunity Announcement. Accordingly, this modification: Inserted new Exploratory Topic, Topic M: H2SENSE. See Table 1. Exploratory Topics, Appendix M, and Total Amounts to be awarded on Cover Page. Updated Language in Appendix L Section 5.

The Robert Wood Johnson Foundation (RWJF) is seeking applications for its "Developing Recommendations for Disaggregating Data Within the Asian American Population" grant program. This initiative aligns directly with RWJF's broader mission to advance data equity, particularly by making historically underrepresented populations more visible in data collection, analysis, and reporting. Since 2015, RWJF has consistently supported research and advocacy efforts aimed at updating policies for race and ethnicity data to ensure fair consideration of diverse groups in policy creation, resource allocation, and program design and implementation. The target beneficiaries of this grant are the diverse Asian American population. The program's impact goal is to develop community-informed and evidence-based recommendations for clustering this population into smaller, actionable subgroups for race and ethnicity data collection and analysis. This approach aims to address the historical underrepresentation and lack of visibility of specific Asian American subgroups in data, ultimately leading to more equitable policies and programs that are responsive to their unique needs. The grant program prioritizes a multifaceted research project that will yield practical recommendations for Asian American subgroup categories. The focus is on developing methods that are feasible for real-world implementation, ensuring that the research translates into actionable changes in data practices. Expected outcomes include a comprehensive set of recommendations that guide researchers on how to more accurately and meaningfully disaggregate data within the Asian American population. These recommendations are intended to improve the quality and utility of race and ethnicity data, leading to better-informed decision-making and more equitable outcomes. RWJF's strategic priorities are deeply rooted in advancing health equity, and this grant reflects a key component of that strategy: addressing systemic inequities through improved data. By focusing on data disaggregation, RWJF's theory of change posits that more granular and accurate data will reveal disparities and needs that are currently masked by broad racial and ethnic categories. This enhanced visibility is expected to empower communities, inform evidence-based policy changes, and ultimately contribute to a fairer distribution of resources and opportunities, thereby improving health and well-being for all.

This grant provides $25,000 to nonprofit organizations and community groups in the U.S. to investigate and address environmental factors linked to cancer in underserved communities.

This funding opportunity provides financial support for collaborative geologic mapping projects aimed at identifying and assessing critical mineral resources across the United States, benefiting researchers, state agencies, and organizations involved in geology and natural resource management.